https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-08 / Strahlenther Onkol 2010 Nov;186(11):587-99
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-08 / Strahlenther Onkol 2010 Nov;186(11):587-992010-11-08 00:00:002019-02-15 08:39:20Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-05 / Br. J. Cancer 2010 Oct;103(9):1415-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-05 / Br. J. Cancer 2010 Oct;103(9):1415-212010-10-05 00:00:002019-02-15 08:46:05A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-30 / Clin. Cancer Res. 2010 Nov;16(22):5548-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-30 / Clin. Cancer Res. 2010 Nov;16(22):5548-562010-09-30 00:00:002019-02-15 08:46:03A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-28 / Vaccine 2010 Nov;28(49):7787-96
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-28 / Vaccine 2010 Nov;28(49):7787-962010-09-28 00:00:002019-02-15 08:46:04Dendritic cell vaccine in addition to FOLFIRI regimen improve antitumor effects through the inhibition of immunosuppressive cells in murine colorectal cancer model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-01 / Dan Med Bull 2010 Sep;57(9):B4171
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-01 / Dan Med Bull 2010 Sep;57(9):B41712010-09-01 00:00:002019-02-15 08:46:06Dendritic cell vaccination of patients with metastatic colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Int J Hyperthermia 2010;26(2):108-17
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Int J Hyperthermia 2010;26(2):108-172010-01-01 00:00:002019-02-15 08:39:21Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-12-15 / Clin. Cancer Res. 2009 Dec;15(24):7726-7736
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-12-15 / Clin. Cancer Res. 2009 Dec;15(24):7726-77362009-12-15 00:00:002019-02-15 08:46:08Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-08-08 / Med. Oncol. 2010 Sep;27(3):736-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-08-08 / Med. Oncol. 2010 Sep;27(3):736-422009-08-08 00:00:002019-02-15 08:46:07Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-07-08 / Cochrane Database Syst Rev 2009 Jul;(3):CD006269
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-07-08 / Cochrane Database Syst Rev 2009 Jul;(3):CD0062692009-07-08 00:00:002019-02-15 08:38:00Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-03-03 / Cancer Res. 2009 Mar;69(6):2685-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-03-03 / Cancer Res. 2009 Mar;69(6):2685-932009-03-03 00:00:002019-02-15 08:38:01Coordination of intratumoral immune reaction and human colorectal cancer recurrence